IDBS joining Inforstack in Bejing

IDBS are delighted to presenting at The 2nd Quality Science of Biologics Summit in Beijing on the 25th May.

Ensuring quality in pharma drug development is a challenge, but Quality by Design (QbD) is the way forward. You need more than the current data management software. You need software that supports true QbD and ensures quality through robust risk assessment and data analysis to accelerate your development timeline.

Join IDBS’ Marc Andrew Smith on May 25th to begin realizing this vision for your organization.

Presentation Details

Digital innovation and data requirements to support QbD

Quality by Design (QbD) is a bold vision for ensuring quality in pharma drug development through robust risk management and data analysis. The journey towards this vision starts with improving process understanding and characterization, supported by advances in technology such as high throughput process development as well as advances in data sciences. Current lab software such as electronic lab notebooks (ELN) and laboratory information management systems (LIMS) do not meet the data requirements of QbD, however. In this session IDBS will share how an innovative approach to biopharma lifecycle management supports true QbD and can accelerate development to bring products to market faster.

Speaker: Marc Andrew Smith, Director of Strategic Solutions